Abstract. Tandem mass (MS/MS) spectrometry has become the method of choice for protein identification and has launched a quest for the identification of every translated protein and peptide. However, computational developments have lagged behind the pace of modern data acquisition protocols and have become a major bottleneck in proteomics analysis of complex samples. As it stands today, attempts to identify MS/MS spectra against large databases (e.g., the human microbiome or 6-frame translation of the human genome) face a search space that is 10-100 times larger than the human proteome where it becomes increasingly challenging to separate between true and false peptide matches. As a result, the sensitivity of current state of the art database search methods drops by nearly 38% to such low identification rates that almost 90% of all MS/MS spectra are left as unidentified. We address this problem by extending the generating function approach to rigorously compute the joint spectral probability of multiple spectra being matched to peptides with overlapping sequences, thus enabling the confident assignment of higher significance to overlapping peptide-spectrum matches (PSMs). We find that these joint spectral probabilities can be several orders of magnitude more significant than individual PSMs, even in the ideal case when perfect separation between signal and noise peaks could be achieved per individual MS/MS spectrum. After benchmarking this approach on a typical lysate MS/MS dataset, we show that the proposed intersecting spectral probabilities for spectra from overlapping peptides improve peptide identification by 30-62%.
Introduction
The leading method for protein identification by tandem mass spectrometry (MS/MS) involves digesting proteins into peptides, generating an MS/MS spectrum per peptide, and obtaining peptide identifications by individually matching each MS/MS spectrum to putative peptide sequences from a target database. Many computational approaches have been developed for this purpose, such as Mill [3] , and more recently MS-GFDB [4], yet they all address the same two problems: Given a MS/MS spectrum and a collection of possible peptide sequences, i) find the peptide that most likely produced spectrum and ii) report the statistical significance of the Peptide-Spectrum Match , (denoted PSM) while searching many MS/MS spectra against multiple putative peptide sequences from a target database. Problem (i) is typically addressed by maximizing a scoring function proportional to the likelihood that peptide generated spectrum while solving problem (ii) involves choosing a score threshold that yields an experiment-wide 1% FalseDiscovery Rate (FDR [5] ), usually based on an estimated distribution of PSM scores for incorrect PSMs [6] . Yet a major limitation comes from ambiguous interpretations of MS/MS fragmentation where the true peptide match for a given spectrum may only be the 2 nd or 100,000 th highest scoring over all possible PSMs for the same spectrum [7] . We address this issue as it relates to problem (ii) where the probability of false peptides matching with high score can become common when searching large databases, particularly for meta-proteomics [8] and 6-frame translation [9] searches, thus leading to higher-scoring false matches and stricter significance thresholds resulting in as little as 2% of all spectra being identified [10] since only the highest scoring PSMs become statistically significant even at 5% FDR.
Identifying peptides from a large database is less of a challenge than that of de novo sequencing, where the target database contains all possible peptide sequences. Yet, recent advances in de novo sequencing have demonstrated 97-99% sequencing accuracy (percent of amino acids in matched peptides that are correct) at nearly the same level of coverage (percent of amino acids in target peptides that were matched) as that of database search for small mixtures of target proteins [11, 12] . At the heart of this approach is the pairing of spectra from overlapping peptides (i.e. peptides that have overlapping sequences) to construct spectral networks [13, 14] of paired spectra. It is then shown that de novo sequences assembled by simultaneous interpretation of multiple spectra from overlapping peptides are much more accurate than individual perspectrum interpretations [13] , [15] . Use of multiple enzyme digestions and SCX [16] fractionation is becoming more common in MS/MS protocols to generate broader coverage of protein sequences and yield wider distributions of overlapping peptides, but current statistical methods still ignore the peptide sequence overlaps and separately compute the significance of individual peptides matched to individual spectra [17] .
Given that the set of all possible protein sequences is orders of magnitude larger than the human 6-frame translation (or any other database), application of these de novo techniques to database search should substantially improve peptide identification rates, especially for large databases. Since the original generating function approach showed how de novo algorithms can be used to estimate the significance of PSMs for individual spectra, it is expected that advances in de novo sequencing should consequently translate into better estimation of PSM significance. It has already been shown that spectral networks can be used to improve the ranking of database peptides against paired spectra [18] , but it is still unclear how to accurately evaluate the statistical significance of peptides matched to multiple overlapping spectra. Intuitively, if it is known that these overlapping spectra yield more accurate de novo sequencing then the probability of observing multiple incorrect high-scoring PSMs with overlapping sequences should be lower than the probability of single incorrect peptides
